Courtenay valenti biography of mahatma gandhi

  • Rafal marszalek google scholar
  • Rafal marszalek imperial college london
  • Rafal marszalek contact

    • •

    Editors

    Scientific Reports is run by a team of experienced editors who are experts in their fields. From our Editorial Board Members and Senior Editorial Board to our in-house Editors, we work togetherResearch integrity issue to ensure that your research is expertly handled and that we consider it to be technically sound, scientifically valid, and ultimately suitable for publication.


    Interview with Rafal Marszalek, Chief Editor of Scientific Reports








     

     

    In-house Editors

    Chief Editor: Rafal Marszalek, PhD; Springer Nature, UK

    Rafal's background is analytical and biological chemistry. He did his PhD and postdoctoral research in single-cell proteomics at Imperial College London, UK. He was an editor at Genome Biology before joining Scientific Reports in August 2016.

    ORCID 0000-0003-0316-1363

    Deputy Editor: Elizabeth Mann, PhD; Springer Nature, UK

    Elizabeth has a background in pharmacology and completed her PhD in neuropharmacology at King's Col

  • courtenay valenti biography of mahatma gandhi

    • •

    The 5 Movie Ratings Explained: G, PG, PG-13, R & Nc-17 Meanings

    In 1919, Hollywood was already under scrutiny. In the eyes of hanky-wringing, ultra-conservative watchdog groups, the film business had become a haven for sex and violence, presenting lascivious and salacious material to an unwitting, impressionable public. By 1921, the government was already proposing dozens of pieces of legislation to censor film content and reign in the indecency. The bulk of the proposed laws were draconian and terrible, and several states began forming specialized media censorship boards, each with their own rules. The film industry wouldn't have been able to comply with them all, as each state had a different decency standard. In response to the widespread moral panic, the film industry at large agreed to a means of self-censorship, hiring a conservative Presbyterian minister named Will H. Haysto oversee studio content and make sure no one was being naughty. 

    Initially, Hays met

    •

    Abstract

    Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile. Retrospective data show similar levels of effectiveness to transarterial chemoembolization in intermediate hepatocellular carcinoma, with some bevis of better tolerance. While phase 3 studies comparing Y90-radioembolization to chemoembolization in intermediate hepatocellular carcinoma would be difficult to conduct, studies comparing or combining Y90-radioembolization with sorafenib are under way. Questions also remain about the most suitable modalities for defining the dos to administer. Phase 3 studies are under way to förklara the place of Y90-radioembolization in the algorithm of HCC treatment.

    Key Words: Hepatocellular carcinoma, Radioembolization, Review, Transarter